User profiles for Laura Matrajt
 | Laura MatrajtFred Hutchinson Cancer Research Center Verified email at fredhutch.org Cited by 2754 |
[HTML][HTML] Evaluating the effectiveness of social distancing interventions to delay or flatten the epidemic curve of coronavirus disease
By April 2, 2020,> 1 million persons worldwide were infected with severe acute respiratory
syndrome coronavirus 2. We used a mathematical model to investigate the effectiveness of …
syndrome coronavirus 2. We used a mathematical model to investigate the effectiveness of …
Vaccine optimization for COVID-19: Who to vaccinate first?
Vaccines, when available, will likely become our best tool to control the COVID-19 pandemic.
Even in the most optimistic scenarios, vaccine shortages will likely occur. Using an age-…
Even in the most optimistic scenarios, vaccine shortages will likely occur. Using an age-…
The transmissibility and control of pandemic influenza A (H1N1) virus
Pandemic influenza A (H1N1) 2009 (pandemic H1N1) is spreading throughout the planet. It
has become the dominant strain in the Southern Hemisphere, where the influenza season …
has become the dominant strain in the Southern Hemisphere, where the influenza season …
Optimizing vaccine allocation for COVID-19 vaccines shows the potential role of single-dose vaccination
Most COVID-19 vaccines require two doses, however with limited vaccine supply,
policymakers are considering single-dose vaccination as an alternative strategy. Using a …
policymakers are considering single-dose vaccination as an alternative strategy. Using a …
Strategies for pandemic and seasonal influenza vaccination of schoolchildren in the United States
…, DL Chao, ME Halloran, L Matrajt… - American journal of …, 2009 - academic.oup.com
Vaccinating school-aged children against influenza can reduce age-specific and population-level
illness attack rates. Using a stochastic simulation model of influenza transmission, the …
illness attack rates. Using a stochastic simulation model of influenza transmission, the …
COVID-19 vaccines that reduce symptoms but do not block infection need higher coverage and faster rollout to achieve population impact
Trial results for two COVID-19 vaccines suggest at least 90% efficacy against symptomatic
disease (VE DIS ). It remains unknown whether this efficacy is mediated by lowering SARS-…
disease (VE DIS ). It remains unknown whether this efficacy is mediated by lowering SARS-…
The global transmission and control of influenza
E Kenah, DL Chao, L Matrajt, ME Halloran… - PloS one, 2011 - journals.plos.org
New strains of influenza spread around the globe via the movement of infected individuals.
The global dynamics of influenza are complicated by different patterns of influenza …
The global dynamics of influenza are complicated by different patterns of influenza …
Estimating influenza vaccine efficacy from challenge and community-based study data
In this paper, the authors provide estimates of 4 measures of vaccine efficacy for live,
attenuated and inactivated influenza vaccine based on secondary analysis of 5 experimental …
attenuated and inactivated influenza vaccine based on secondary analysis of 5 experimental …
Could widespread use of antiviral treatment curb the COVID-19 pandemic? A modeling study
Background Despite the development of safe and effective vaccines, effective treatments for
COVID-19 disease are still urgently needed. Several antiviral drugs have shown to be …
COVID-19 disease are still urgently needed. Several antiviral drugs have shown to be …
Optimizing vaccine allocation at different points in time during an epidemic
L Matrajt, IM Longini Jr - PloS one, 2010 - journals.plos.org
Background Pandemic influenza A(H1N1) 2009 began spreading around the globe in April
of 2009 and vaccination started in October of 2009. In most countries, by the time vaccination …
of 2009 and vaccination started in October of 2009. In most countries, by the time vaccination …
